Related Experiment Videos
[Chemotherapy and DPC, prospective payment].
1Statistics and Cancer Control Division, Research Center for Cancer Prevention and Screening, National Cancer Center.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|February 18, 2006
Summary
Japan
Area of Science:
- Health economics
- Oncology
- Health services research
Context:
- In 2003, Japan implemented a prospective payment system for acute inpatient care using Diagnosis Procedure Combination (DPC) patient grouping.
- This system aimed to standardize healthcare costs and improve efficiency in acute care settings.
Purpose:
- To address challenges arising from the DPC system, including cost settlement for combined treatments, variations in chemotherapy practices, and the impact of shorter hospital stays.
- To propose solutions for refining the DPC system and managing healthcare costs in oncology.
Summary:
- The introduction of Diagnosis Procedure Combination (DPC) in Japan's acute inpatient care highlighted issues in cost allocation, chemotherapy practice variations, and care intensity adjustments.
- Recommendations include developing oncology treatment guidelines, standardizing chemotherapy, refining DPC to include protocols, and implementing casemix adjustments for complex cases.
Impact:
- Standardizing chemotherapy regimens and refining DPC can lead to more equitable and efficient healthcare payments.
- Improved DPC adjustments are crucial for accurately compensating hospitals managing terminally ill, relapsed, or metastatic cancer patients.